From: Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1β
Genes whose RNA levels were reduced >80% relative to untreated control cultures | |||
---|---|---|---|
• A disintegrin and metaloproteinase domain 33 | • c-fos-induced growth factor (vascular endothelial growth factor D) | Kruppel associated box zinc finger 1 | • Smoothelin |
• Actin alpha 1 | • Collagen type II alpha 1, chain precursor | • Microfibril-associated glycoprotein precursor | Solute carrier family 39 (iron-regulated transporter), member 1 |
Aggrecan 1 | Crystallin, alpha B | • Midline 1 | • Sphingomyelin phosphodiesterase 3, neutral |
• Ankyrin-like repeat protein | Distal-less homeobox | • Mitochondrial ribosomal protein L53 | • Transforming growth factor, beta 2 |
• Annexin III (Lipocortin III) | • DVS27-related protein | Myocilin precursor | • Zinc finger protein SLUG (neutral crest transcription factor Slug) |
Cadherin-8 precursor | • Dynein, cytoplasmic, intermediate chain 1 | • NAD-dependent 15-hydroxyprostaglandin dehydrogenase | |
Calpain 6 | • Enolase 3, beta | Osteomodulin (osteoadherin) | |
• Carbonic anhydrase 3 | Four and a half LIM domains 1 | • Palmdelphina | |
Cartilage link protein 1 a | • Heat shock protein HSP 90 betaa | • Phosphoribosyl pyrophosphate synthestase 2 | |
• Caveolin 3 | Insulin-like growth factor binding protein 4 precursor | • Programmed cell death protein 7 | |
Genes whose RNA levels were increased more than fivefold relative to untreated controls | |||
Adaptor protein with pleckstrin homology and src homology 2 domains | Cyclooxygenase-2 | Keratin, type II cryosqueletal 8 | Plasminogen activator, urokinase receptor |
Adenosine A2B receptor | Cytochrome P450, family 26, subfamily b, polypeptide 1 | Lactose operon repressor | Prostaglandin E synthase a |
Adenosine monophosphate deaminase 3 | Cytochrome P450, subfamily 7B, polypeptide 1a | Laminin beta-2 chain precursor | Purigenic receptor P2Y, G-protein coupled 2 |
Aldose reductase-like protein | Cytokine-induced neutrophil chemoattractant-2a | MAP-kinase phosphatase (cpg21) | RAB27B, member RAS oncogene family |
Apoptotic death agonist BID | EGL nine homolog 3 (C. elegans) | Matrix metalloproteinase 3 | Rat VL30 element a |
Arginosuccinate synthetase | Endothelial cell-specific molecule 1 | Matrix metalloproteinase 9a | Receptor-interacting serine-threonine kinase 2 |
ATP-binding cassette, sub-family G (WHITE), member 1 | Epiregulin precursor | Matrix metalloproteinase 10 | RelB |
BCL2-related protein A1 | Fatty acid binding protein 4 | Matrix metalloproteinase 12 | Retinol-binding protein 1 |
Beta-nerve growth factor | F-box protein Fbx5 | • Matrix metalloproteinase 13 | • Ring finger protein 28 |
Bloom's syndrome protein homolog (mBLM) | Fibroblast growth factor 9 | Mesothelin | Schlafen 4 |
Bone morphogenetic protein 2a | Follistatin | Microtubule-associated protein | Small inducible cytokine A2 |
Bone morphogenetic protein 6a | Fos-like antigen 1 | 6 a | Smhs1 protein |
Bone morphogenetic protein 7 | Gardner-Rasheed feline sarcoma viral (Fgr) oncogen homolog | Mitochondrial solute carrier protein | Solute carrier family 1, member 1 |
Brain-specific angiogenesis inhibitor 1-associated protein 2 | GATA-binding protein 2 | Myotubularin related protein 7 | Solute carrier family 1, member 3 |
CCL3 (Mip-1a) | Gro | NADH-ubiquinone oxidoreductase MLRQ subunit | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
CCL5 (RANTES) | Growth arrest specific 7 | Neurofilament, heavy polypeptide | Solute carrier family 11, member 2 |
CCL7 (MCP-3) | GTP cyclohydrolase 1 | Neuron specific protein PEP-19 (Purkinje cell protein 4) | Solute carrier family 20 (phosphate transporter), member 1 |
CD44 antigen | High mobility group AT-hook 1 | Neuropeptide Y | Superoxide dismutase 2 |
Chemokine receptor (LCR1)a | IκB-α | Neurospin precursor | T-cell death associated gene |
Cholesterol 15-hydroxylase | IκB-β (nuclear factor kappa B p105 subunit) | Nitric oxide synthase 2 | Testis-specific protein Bs13 |
Claudin-3 | Inhibin beta-A | Organic cation transporter OCTN1 | Tissue factor pathway inhibitor 2 |
Colony stimulating factor 2 (granulocyte-macrophage) | Inhibitor of apoptosis protein 1 | Parvalbumin | Tissue-type transglutaminase |
Colony stimulating factor 3 | Insulin-like growth factor-binding protein 5 | Phosphodiesterase 4B, cAMP-specific (dunce (Drosophila) homolog phosphodiesterase E4) | Toll-like receptor 2 |
Complement factor B precursor (C3/C5 convertase) | Interleukin 1 alpha | Phospholipase A2, group 5 | Tumor necrosis factor alpha-induced protein 2a |
CXCL1 (GROa) | Interleukin 1 beta | Phospholipase A2, group IIA (platelets, synovial fluid) | Tumor necrosis factor receptor superfamily member 5 precursor |
CXCL2 (GROb) | Interleukin 6 (interferon, beta 2) | Phospholipid scramblase 1 | Tumor necrosis factor receptor superfamily member 9 precursor |
CXCL5 (LIX) | Interleukin 23, alpha subunit p19 | Plasminogen activator inhibitor 2 type A | Uridine phosphorylase |
CXCL10 (IP-10) | • Interleukin 13 receptor, alpha 2 | Plasminogen activator, tissue |